Conference Coverage

Idiopathic pulmonary fibrosis a ‘robust diagnosis’


 

REPORTING FROM RHEUMATOLOGY 2018


“A very small number of patients with IPF actually have the presence of autoantibodies strongly associated with CTDs. This suggests IPF is a very robust diagnosis; chest physicians are diagnosing it correctly most of the time, and they are really good at good at weeding out those who have got IPF and those who have potentially got connective tissue disease.” Dr. Cotton concluded.

Dr. Cotton had no conflicts of interest.

SOURCE: Cotton CV et al. Rheumatology. 2018;57[Suppl. 3]:key075.206.

Pages

Recommended Reading

MDedge Daily News: Lupus is quietly killing young women
MDedge Internal Medicine
Heart disease in GPA exacts high toll in year 2 and beyond
MDedge Internal Medicine
Even a year of increased water intake did not change CKD course
MDedge Internal Medicine
VIDEO: Skin exam crucial in rheumatic diseases, expert says
MDedge Internal Medicine
VIDEO: Characteristic flora define intestinal microbiome in scleroderma
MDedge Internal Medicine
VIDEO: Calming microglia might control fibromyalgia
MDedge Internal Medicine
Don’t trust interface dermatitis to diagnose dermatomyositis
MDedge Internal Medicine
Median time to progression from discoid to systemic lupus may be less than a year
MDedge Internal Medicine
Timely dermatomyositis diagnosis, treatment remain elusive
MDedge Internal Medicine
Hydroxychloroquine throws off Quantiferon-TB Gold results, study finds
MDedge Internal Medicine